KFA
VKTX icon

Kabarec Financial Advisors’s Viking Therapeutics VKTX Stock Holding History

Kabarec Financial Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$97K Buy
+10,250
New +$68.2K 0.07% 50

Other funds holding VKTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kabarec Financial Advisors's VKTX Position: Q2 2018 in Review

Kabarec Financial Advisors opened a new position in Viking Therapeutics (VKTX) in Q2 2018: 10,250 shares worth $97K. The stake represents 0.07% of the portfolio and ranks #50 among its holdings.

116 funds tracked by Wall St. Rank hold VKTX as of Q2 2018.

  • Kabarec Financial Advisors held 10,250 shares of Viking Therapeutics worth $97K as of Q2 2018.
  • Viking Therapeutics was a new Kabarec Financial Advisors position in Q2 2018.
  • Viking Therapeutics made up 0.07% of Kabarec Financial Advisors's portfolio in Q2 2018, its #50 holding.
  • 116 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2018.

Based on Kabarec Financial Advisors's 13F filing for Q2 2018, filed 9 Aug 2018.